Stocks · News reference

Aclarion CEO Says In Letter To Shareholders Company Saw 141% Year-Over-Year Scan Volume Growth In First Half Of 2026; $16.3M Cash, No Debt With Runway Into Second Half Of 2027

Jul 29, 2026, 11:04 AMBenzinga Newsdesk

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Jul 29, 2026, 11:04 AM
Checked: Jul 29, 2026, 11:04 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 20, 2026, 11:01 AMBenzinga Newsdesk
Aclarion Announces University Of Arizona College Of Medicine - Phoenix As New Clinical Site In Its CLARITY Trial
Read original at benzinga
ACON
BenzingaAug 12, 2026, 11:04 AMBenzinga Newsdesk
Aclarion Says USPTO Issues Notice Of Allowance For U.S. Patent Application Titled Multi-Voxel Prescription For Lumbar Disc Evaluation
Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflowDesigned to reduce scan time, support faster technologist onboarding and deliver more reproducible
Read original at benzinga
ACON
BenzingaJul 7, 2026, 11:06 AMBenzinga Newsdesk
Aclarion Announces Texas Spine Care Center As New Clinical Site In Chronic Low bAck pain Randomized Independent Trial studY Trial
Read original at benzinga
ACON